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A 45-year-old woman presented with gross hematuria. She had previously undergone an aortobifemoral bypass that
subsequently became infected. The infected graft was removed and replaced with homograft. An arterioureteric ﬁstula
was identiﬁed with angiography and the patient was treated with an iCast stent graft. Diagnosis of arterioureteric ﬁstula
should be suspected in patients with gross hematuria and associated risk factors. We would recommend angiography
for diagnosis and simultaneous treatment with a stent graft, although the long-term durability and outcome is
unknown. (J Vasc Surg 2014;59:1701-4.)Arterial-ureteral ﬁstulas (AUFs), ﬁrst reported by
Moschcowitz in 19081 are rarely reported but can lead to
lethal hemorrhage if not promptly diagnosed and treated.
We present a case report with a review of the literature
over the past 60 years to highlight diagnosis and treatment
of this unusual condition.CASE REPORT
A 45-year-old woman presented with right ﬂank pain and gross
hematuria. The patient had undergone an urgent aorto-bi-iliac
bypass at an out-of-state hospital for critical limb ischemia in
May 2010. One year later, she developed a graft infection associ-
ated with sepsis and hypotension. The patient was treated at
another hospital where she underwent resection of the entire pros-
thetic graft and in-line replacement with homograft. The left colon
was noted to be ischemic at the time of the operation, requiring
a colectomy and colostomy. Seven months after homograft place-
ment, a left iliac pseudoaneurysm developed and was treated with
a covered stent graft, again diagnosed and treated at another insti-
tution. (At the time of treatment for her AUF, the stent was
occluded [Fig 1], but the patient was without signs or symptoms
of critical limb ischemia). The patient had a history of renal calculi
ﬁrst diagnosed in 1991. She developed bilateral ureteral obstruc-
tion with hydronephrosis felt to be due to renal calculi for which
an outside urologist placed ureteral stents. The urologists at our
institution saw her in March 2012, and in April, she underwent
bilateral urteroscopy and stone removal. Her presentation with
gross hematuria and ﬂank pain occurred 13 months after the
homograph had been implanted, approximately 10 months after
the left ureteral stent had been placed and 5 months after the right
ureteral stent had been placed. She was taken to the cystoscopy
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With irrigation, the thrombus in the ureter was dislodged, result-
ing in large-volume hemorrhage. The patient was immediately
transferred to the hybrid operating room. An initial angiogram,
taken in an anterior-posterior projection, showed no abnormalities
(Fig 1, A). A second view with cranial-caudal orientation revealed
a small pseudoaneurysm located in the right iliac homograft limb
with extravasation (Fig 1, B). An 8-  59-mm iCast stent (Atrium
Medical Corporation, Hudson, NH) was deployed across the
pseudoaneurysm with cessation of hemorrhage (Fig 2). The
ureteral stents were removed, and bilateral nephrostomy tubes
were placed. The patient had positive blood cultures for Klebsiella
pneumoniae for which she was given a 7-day course of intravenous
meropenum followed by a 6-week course of oral ertapenem. She
had no further episodes of bleeding. Eight weeks following
discharge, the patient was readmitted with fever and chills. A
computed tomography scan demonstrated a pelvic ﬂuid collection
that was percutaneously drained with resolution of her fever.
(Cultures grew 95% skin ﬂora and 4% Klebsilla pneumoniae.)
Follow-up computed tomography angiogram 2.5 months after
stent deployment demonstrated patency of the stent graft and no
evidence of infection (Fig 3). She has not kept follow-up
appointments.
DISCUSSION
AUFs are rarely encountered but if undiagnosed and
untreated may be lethal. AUFs have been classiﬁed as
primary, secondary, or pregnancy-related.2,3 Pregnancy-
related AUFs are rare; only three have been reported.
Each was associated with sepsis from severe urinary tract
infection, and none has been reported in recent years.2
Primary AUFs develop with erosion of an aneurysm into
the ureter. Secondary AUFs form when predisposing
factors such as prior irradiation, indwelling ureteral stent,
prior pelvic surgery (including prior aortic or iliac vascular
procedures), or a history of pelvic cancer result in erosion
of an artery into the ureter.
Most AUFs are reported as isolated cases. A review of
the English literature since 1955 identiﬁed 42 reports doc-
umenting 84 cases of AUF in 81 patients (including the
current case). Thirty-four are single case reports of AVF.
The other eight reports contain between two and 20
patients, the largest series being published by the Mayo
Clinic.4-13 Interestingly, the majority (23) of reports have1701
Fig 1. A, Anterior-posterior angiogram demonstrating occlusion
of the left limb of the homograft but no obvious abnormality
involving the right graft limb. The previously placed iliac stent is
occluded. B, Cranio-caudal angiogram demonstrating a small
pseudoaneurysm (arrow) in the right graft limb. Contrast extrava-
sation can be seen as a blush superior to the graft limb (arrowheads).
Fig 2. Angiogram following deployment of the iCast stent. The
pseudoaneurysm and extravasation are no longer seen.
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few (7) in vascular literature. Patient characteristics, predis-
posing factors, ureter and vessel involved, and treatment is
summarized in the Table. As was seen in the current case,
a history of prior pelvic radiation, prior pelvic surgery,
indwelling ureteral stent, prior vascular procedure, or pres-
ence of aneurysmal disease are predisposing factors. Often,
more than one of these factors is present. All but one
patient presented with gross hematuria, often to an extent
that caused hypotension and the need for blood transfu-
sion. It stands to reason, as has been stated in prior
reviews,2,3,14 that the combination of massive hematuria
with a predisposing risk factor should alert the clinicianto have a high index of suspicion that an AUF may be
the cause of the hematuria.
There is no consistency regarding the optimal study used
to diagnose an AUF.Many patients with gross hematuria are
likely to undergo cystoscopy. Findings at cystoscopy that
should be of concern for AUFs are bleeding emanating
from one ureter and evidence of severe hemorrhage such
as a large volume of blood in the bladder, need for transfu-
sion, pulsatile bleeding from an ureter oriﬁce, and clinical
signs of hemorrhage. Should these ﬁndings be present, we
would recommend that thrombus extruding from the ureter
not be removed, rather the patient should be transferred to
a hybrid operating room, and an arteriogram should be
immediately obtained. In those patients with risk factors
for developing AUF, it may be prudent to perform cysto-
scopy in a hybrid operating room where diagnosis, control
of the bleeding with balloon tamponade, and treatment
with a stent graft can be done. Findings on arteriography
may be subtle, as was seen in the current case, and may
require provocative arteriography.6,14 Provocative angio-
graphy involves agitating the artery in the area of the ﬁstula
such that thrombus is dislodged from the ﬁstula, thereby
allowing visualization and identiﬁcation of the ﬁstula.
When such maneuvers are performed, the interventionalist
must be prepared to tamponade the bleeding, usually with
an occlusion balloon positioned at or near the site of the
ﬁstula.2,3,6 An additional beneﬁt of angiography is that it
allows for therapeutic intervention, usually with a stent graft.
Historically, treatment has been accomplished through
an open approach in which the ﬁstulous connection
between the affected artery and ureter is disconnected.
The surgeon is then faced with two additional problems:
management of the artery and management of the ureter.
Arterial management is, in part, dependent on vessel loca-
tion. The internal iliac artery can be ligated. The common
iliac and external iliac arteries should either be repaired
primarily or with a vein patch, or ligated with an extra-
anatomic bypass done to preserve limb perfusion. Depend-
ing on the contamination, it may be appropriate to use an
Fig 3. Follow-up computed tomography angiogram. Note the
close anatomic relationship between the ureter and the stent graft.
A, Axial section. B, Sagittal section.
Table. Summary of literature reports of AUF since 1955
Patient factor
Average age, years, 6 SD 61.9 6 15.6
Gender (female), No. (%) 52/81 (64)
Predisposing factors
Ureteral stent, No. (%) 58/84 (69)
History of pelvic radiation, No. (%) 30/61 (49)
History of pelvic surgery, No. (%) 39/61 (64)
Prior malignancya
Gynecologic 28
Bladder 13
Colorectal 11
Otherb 5
Prior vascular surgery 18
Untreated aneurysm 4
Diagnosis
Gross hematuria,c No. (%) 83/84 (99)
Diagnostic method
Surgery 20
Necropsy 3
Angiography 34
Cystoscopy/ureteroscopy 13
Computed tomography scan 7
Retrograde pylography 4
Side involved
Right 42
Left 39
Unknown 3
Artery involved
Common iliac artery 48
External iliac artery 18
Internal iliac artery 7
Graft/anastomosis 9
Inferior mesenteric artery 1
Treatment
1955-1996
None (necropsy) 3
Open repair 26
1997-present
Covered stent graft 33
Otherd 22
AUF, Arterial-ureteral ﬁstula; SD, standard deviation.
aOne patient had a history of both colon and endometrial cancer.
bSarcoma (4), lymphoma (1).
cOne patient was found to have arterial-ureteral ﬁstulas on retrograde
pylography between a graft limb and ureter.
dCoil embolization of iliac artery and extra-anatomic bypass (8), iliac artery
ligation and extra-anatomic bypass (5), primary repair (6), nephrectomy (1),
ureteral embolization (1), graft limb occluder (1).
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ureter can involve ligation (with or without nephrectomy),
primary repair (usually associated with extra-anatomic arte-
rial bypass), reimplantation to a site away from the vessels,
or diversion of the urine with a nephrostomy tube. In
many, if not most, patients, an open operation is difﬁcult
and morbid due to the associated risk factors, namely, prior
pelvic irradiation and/or pelvic surgery, and hemodynamic
instability from the hemorrhage. For these reasons, an
endovascular approach with a covered stent graft has
become very appealing.14 Since 1996, most patients have
had a stent graft used for the treatment for AUF (Table).
The long-term outcome and durability, including
concern for the development of infection of a stent graft
placed for AUF, is unknown. In the current report, we
initially managed the patient with intravenous antibiotics
and then a 6-week course of oral antibiotics. She developed
a pelvic abscess that was percutaneously drained, and
follow-up computed tomography scan 2.5 months
following stent graft placement and 1 month after the
abscess drainage showed no evidence of graft infection.
Extended antibiotic treatment with long-term follow-upshould be considered in patients with AUF treated with
a stent graft. The Mayo Clinic group has suggested that
arterial ligation or coil embolization with extra-anatomic
bypass be done in patients with localized infection. In their
series, one patient was treated with a stent graft as a bridge
to control massive hemorrhage, with deﬁnitive treatment
being arterial ligation and extra-anatomic bypass. Occlu-
sion of a stent graft used to treat an AUF has been re-
ported15 8 months following deployment. It is has been
suggested that another long-term complication in patients
treated with stent grafts is the redevelopment of another
ﬁstula, since the ﬁstulous connection has not been cor-
rected.2 We would recommend that every effort should
also be made to remove an indwelling ureteral stent, either
placing nephrostomy tubes or diverting the ureter away
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unknown, it is mandatory that patients with AUF treated
using a covered stent should be followed for life.
CONCLUSIONS
In summary, AUF is a life-threatening condition. The
diagnosis should be suspected in patients who present
with massive hematuria who also have had pelvic surgery,
pelvic irradiation, and/or have an indwelling ureteral stent.
Angiography, with or without provocative maneuvers,
may be the diagnostic study of choice, and currently, place-
ment of a covered stent graft is recommended to control
the life-threatening hemorrhage. Long-term follow-up is
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